Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

Fig. 4

The effects of slc10a2 on apoptosis of A549 cells treated with bexarotene. a The apoptosis rate of A549 cells treated with 0.1 mM bexarotene, overexpressed slc10a2 in combination with 0.1 mM bexarotene, slc10a2-shRNA in combination with 0.1 mM bexarotene respectively; b The apoptosis rate of A549 cells treated with 1 mM bexarotene, overexpressed slc10a2 in combination with 1 mM bexarotene, slc10a2-shRNA in combination with 1 mM bexarotene respectively; c The apoptosis rate of A549 cells treated with 10 mM bexarotene, overexpressed slc10a2 in combination with 10 mM bexarotene, slc10a2-shRNA in combination with 10 mM bexarotene respectively, A549 cells without any treatment as control group (d). All experiments were repeated 3 times

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us